OHR Pharmaceutical Inc.

Overview

Company Info

Ohr Pharmaceutical, Inc. (Nasdaq: OHRP)

Ohr Pharmaceutical, Inc. (OHRP) is a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases. The company has completed two clinical trials with squalamine lactate ophthalmic solution, 0.2%, for the treatment of the wet form of age-related macular degeneration.  In addition, Ohr has a sustained-release micro-fabricated micro-particle ocular drug delivery platform technology.

Contact Info

Company Information

Ohr Pharmaceutical, Inc.
800 Third Avenue
11th Floor
New York, NY 10022

Investor Relations

LifeSci Advisors
Michael Rice
646-597-6979
mrice@lifesciadvisors.com

Stock Info

OHRP
Nasdaq

Q2 2018 Quarterly Results

Recent News